Accelevir designs and executes viral persistence models to evaluate therapeutic strategies targeting chronic infection.
- In Vitro and Ex Vivo Latency Models – For HIV, HBV, and other persistent viral infections.
- Longitudinal Sampling & Analysis – Tracking viral reservoirs over extended timeframes.
- Integrated Molecular & Immune Readouts – Assessing both residual viral genomes and immune control mechanisms.
- Therapeutic Intervention Studies – Evaluating cure strategies, latency-reversing agents, and immune-modulatory approaches.